Assessment of the invisible blood contamination on nurses' gloved hands during vascular access procedures in a hemodialysis unit.

A prospective study was conducted to assess potential invisible blood contamination on nurses' gloved hands during vascular access procedures using the occult blood detection method in a hemodialysis unit. 60.13% (273/454) of samples tested positive for hemoglobin. These results highlighted the importance of hand hygiene and glove change during hemodialysis access care.

Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay.

Aß42 is one of the most extensively studied blood and Cerebrospinal fluid (CSF) biomarkers for the diagnosis of symptomatic and prodromal Alzheimer's disease (AD). Because of the heterogeneity and transient nature of Aß42 oligomers (Aß42Os), the development of technologies for dynamically detecting changes in the blood or CSF levels of Aß42 monomers (Aß42Ms) and Aß42Os is essential for the accurate diagnosis of AD. The currently commonly used Aß42 ELISA test kits usually mis-detected the elevated Aß42Os, leading to incomplete analysis and underestimation of soluble Aß42, resulting in a comprised performance in AD diagnosis. Herein, we developed a dual-target lateral flow immunoassay (dLFI) using anti-Aß42 monoclonal antibodies 1F12 and 2C6 for the rapid and point-of-care detection of Aß42Ms and Aß42Os in blood samples within 30 min for AD diagnosis. By naked eye observation, the visual detection limit of Aß42Ms or/and Aß42Os in dLFI was 154 pg/mL. The test results for dLFI were similar to those observed in the enzyme-linked immunosorbent assay (ELISA). Therefore, this paper-based dLFI provides a practical and rapid method for the on-site detection of two biomarkers in blood or CSF samples without the need for additional expertise or equipment.